Literature DB >> 9099123

Science, medicine, and the future. Non-insulin dependent diabetes mellitus: the gathering storm.

S O'Rahilly1.   

Abstract

A massive increase in the global prevalence of non-insulin dependent diabetes is likely to occur as "Westernisation" of dietary habits and patterns of physical activity becomes more widespread. Advances in molecular and cellular science may provide some useful insights and therapeutic tools to assist in the fight against the severe consequences of this epidemic. These will include the better identification of specific aetiological subtypes of the disease; the identification of new drugs through the better understanding of the biology of insulin secretion and action; and the targeting of therapies to specific subtypes of the disease. In addition, knowledge of the precise mode of action and antidiabetes drugs may facilitate the design of more effective non-pharmacological manipulations; the genetic identification of "high risk" asymptomatic people may allow us to target screening and preventive strategies more effectively; and investigations into the mechanisms that underlie the link between low birth weight and later diabetes should provide new routes towards treatment and prevention. Barriers to the implementation of the global measures required to stem the predicted flood of non-insulin dependent diabetes may prove insuperable, but if we are to have any success, then close collaboration between clinicians, epidemiologists, public health physicians, and laboratory scientists will be essential.

Entities:  

Mesh:

Year:  1997        PMID: 9099123      PMCID: PMC2126397          DOI: 10.1136/bmj.314.7085.955

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  21 in total

Review 1.  Cellular mechanisms of insulin resistance.

Authors:  G I Shulman
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

2.  Balancing benefits and risks in patients receiving incretin-based therapies: focus on cardiovascular and pancreatic side effects.

Authors:  Martin Haluzík; Miloš Mráz; Štěpán Svačina
Journal:  Drug Saf       Date:  2014-12       Impact factor: 5.606

3.  Preventing diabetes in south Asians.

Authors:  Tahseen A Chowdhury; Clare Grace; Peter G Kopelman
Journal:  BMJ       Date:  2003-11-08

Review 4.  Emerging paradigms for understanding fatness and diabetes risk.

Authors:  Steven R Smith; Eric Ravussin
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

5.  Sleep and Glucose Intolerance/Diabetes Mellitus.

Authors:  Mary Ip; Babak Mokhlesi
Journal:  Sleep Med Clin       Date:  2007

6.  The changing classification and diagnosis of diabetes. New classification is based on pathogenesis, not insulin dependence.

Authors:  N J Wareham; S O'Rahilly
Journal:  BMJ       Date:  1998-08-08

7.  Maternal and paternal family history of type 2 diabetes differently influence lipid parameters in young nondiabetic Japanese women.

Authors:  Kemal Sasaki; Aya Yoshida; Hiroshi Ohta; Yoshiharu Aizawa; Akiko Kojima; Hitomi Chiba; Shin Mizuguchi; Tatsunori Ishidzuka; Hiroshi Goto; Chiho Uegaki; Kyuhei Kotake
Journal:  Environ Health Prev Med       Date:  2012-07-25       Impact factor: 3.674

Review 8.  Troglitazone: a review of its use in the management of type 2 diabetes mellitus.

Authors:  G L Plosker; D Faulds
Journal:  Drugs       Date:  1999-03       Impact factor: 9.546

Review 9.  Glucose and insulin management in the post-MI setting.

Authors:  Patrick H McNulty
Journal:  Curr Diab Rep       Date:  2002-02       Impact factor: 4.810

10.  Leptin suppression of insulin secretion and gene expression in human pancreatic islets: implications for the development of adipogenic diabetes mellitus.

Authors:  J Seufert; T J Kieffer; C A Leech; G G Holz; W Moritz; C Ricordi; J F Habener
Journal:  J Clin Endocrinol Metab       Date:  1999-02       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.